Clinical Trials Logo
  1. Home
  2. Hip Fractures
  3. NCT05429749
  4. Details
NCT05429749 Clinical Trial

Intravenous Iron Supplement to Prevent Postoperative Delirium After Hip Fracture Surgery

Hip Fractures Clinical Trial

Official title:
Intravenous Iron Supplement to Prevent Postoperative Delirium After Hip Fracture Surgery

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05429749
Other study ID # Ferinject
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date July 30, 2020
Est. completion date December 31, 2024

Study information
Verified date June 2022
Source Seoul National University Bundang Hospital
Contact Jung-Wee Park, M.D.
Phone 82-10-2255-7726
Email jwepark@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a clinical trial to evaluate the effect of intravenous iron supplement with Ferinject (Ferric Carboxymaltose) in preventing postoperative delirium after hip fracture surgery.

Description:

We hypothesized that IV iron supplement will (1) decrease postoperative delirium in hip fracture patients and (2) decrease the amount of transfusion and transfusion-related complications.

Recruitment information / eligibility
Status Recruiting
Enrollment 264
Est. completion date December 31, 2024
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - femur neck fracture, intertrochanteric fractures - Iron deficiency anemia (Hb<12 in women, Hb<13 in men) - Iron deficiency (Serum ferritin <100ug/L or transferrin saturation<20%) - Who understands this clinical trial and volunteers and agrees to this trial Exclusion Criteria: - Patient under the age of 65 years - Hb<7 or someone who has acute symptom of anemia(tachycardia, dyspnea, or dizziness) - High energy trauma - Preoperative delirium - MMSE<10 - Underlying disease which involves cognitive dysfunction (e.g. neurovascular diseases, acute myocardial infarction, pulmonary embolism) - Those who are inappropriate to participate in the clinical trial assessed by the investigators

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Ferinject
Intravenous ferinject 1000mg is administered between the admission day and the surgery day.
• Normal saline
Normal saline 250ml is administered between the admission day and the surgery day.

Locations
Country Name City State
Korea, Republic of Seoul National University Bundang Hospital Seongnam

Sponsors (2)
Lead Sponsor Collaborator
Seoul National University Bundang Hospital JW Pharmaceutical

Country where clinical trial is conducted

Korea, Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary Postoperative delirium The presence and duration of postoperative delirium since immediately after the surgery to the discharge date
Secondary Postoperative transfusion The amount of postoperative transfusion Postoperative admission datessince immediately after the surgery to the discharge date
Secondary Transfusion-related complications The presence of transfusion-related complications since immediately after the surgery to the discharge date
Secondary Functional outcomes Postoperative functional outcomes of hip fracture patients since immediately after the surgery to the discharge date
Secondary Hematologic outcomes Postoperative hematologic outcomes of hip fracture patients since immediately after the surgery to the discharge date
See also
  Status Clinical Trial Phase
Completed NCT02507609 - Deep Neuromuscular Block on Cytokines Release and Postoperative Delirium N/A
Completed NCT03906864 - Care Pathway for Sub-acute Hip Rehabilitation N/A
Recruiting NCT04063891 - Vibration Therapy as an Intervention for Enhancing Trochanteric Hip Fracture Healing in Elderly Patients N/A
Completed NCT05039879 - Life Improving Factors After a Hip Fracture
Not yet recruiting NCT03887494 - Study of the Impact of the Femoral Implant "Y-strut" on Lytic Bone Metastases of the Femoral Neck (WAZA-ARY) N/A
Terminated NCT03065101 - Trigen InterTAN vs Sliding Hip Screw RCT N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Completed NCT03545347 - Physiotherapy, Nutritional Supplement and Anabolic Steroids in Rehabilitation of Patients With Hip Fracture. Phase 2
Recruiting NCT05971173 - Nutritional Optimization and Bone Health Management for Older Adults Undergoing Hip Fracture Surgery Early Phase 1
Active, not recruiting NCT04957251 - Anterior vs Posterior Approach for Hip Hemiarthroplasty N/A
Terminated NCT04372966 - Uncemented Versus Cemented Total Hip Arthroplasty for Displaced Intracapsular Hip Fractures N/A
Withdrawn NCT05030688 - Fascia Iliaca Compartment Block and PENG Block for Hip Arthroplasty N/A
Completed NCT04424186 - 'Rehabilitation for Life' N/A
Not yet recruiting NCT04183075 - Impact of a Nutritional Supplement on the Recovery of the Nutritional Status of Patients With Spontaneous Hip Fracture N/A
Withdrawn NCT05518279 - Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures Phase 3
Not yet recruiting NCT02892968 - ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients N/A
Not yet recruiting NCT02223572 - Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture N/A
Active, not recruiting NCT02247791 - Uncemented Compared to Cemented Femoral Stems in Total Hip Arthroplasty N/A
Completed NCT00746876 - Unipolar or Bipolar Hemiarthroplasty in the Treatment of Displaced Femoral Neck Fractures. N/A
Completed NCT00058864 - The HIP Impact Protection Program (HIP PRO) N/A